Earth Science Tech Engages Hayden IR to Enhance Investor Relations and Market Awareness
Summary
Earth Science Tech, Inc. has engaged Hayden IR to enhance its investor relations and market communication strategy, aiming to improve market awareness during a period of growth and strong financial performance.
Key Events · Corporate Governance and Compliance · ETST
-
Investor Relations Engagement
Earth Science Tech announced the engagement of Hayden IR, a nationally recognized firm, to manage its investor outreach and communications.
-
Strategic Growth Phase
The engagement supports the company's strategy of scaling its businesses and entering an important phase of growth and market repositioning.
-
Strong Financial Performance Highlighted
The company highlighted H1 FY26 revenues of $17.8 million, net income of $1.4 million, operating cash flow of $1.18 million, and gross margins exceeding 70%.
-
CEO Shareholder Alignment
The CEO holds over 122 million shares, acquired entirely with cash, demonstrating strong alignment with shareholder interests.
Analysis · ETST · Life Sciences
The engagement of Hayden IR is a strategic move for Earth Science Tech, signaling a concerted effort to improve communication with the investment community. This comes as the company reports strong financial performance for the first half of fiscal 2026, including $17.8 million in revenue and over 70% gross margins, which it aims to better convey to investors. The move is intended to support the company's growth phase and market repositioning, potentially leading to increased investor interest and improved valuation.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ETST was trading at $0.13 on OTC in the Life Sciences sector, with a market capitalization of approximately $38M. The 52-week trading range was $0.00 to $0.25. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.